Cargando…

A dual protease approach for expression and affinity purification of recombinant proteins

We describe a new method for affinity purification of recombinant proteins using a dual protease protocol. Escherichia coli maltose binding protein (MBP) is employed as an N-terminal tag to increase the yield and solubility of its fusion partners. The MBP moiety is then removed by rhinovirus 3C prot...

Descripción completa

Detalles Bibliográficos
Autores principales: Raran-Kurussi, Sreejith, Waugh, David S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877217/
https://www.ncbi.nlm.nih.gov/pubmed/27105777
http://dx.doi.org/10.1016/j.ab.2016.04.006
_version_ 1782433348967202816
author Raran-Kurussi, Sreejith
Waugh, David S.
author_facet Raran-Kurussi, Sreejith
Waugh, David S.
author_sort Raran-Kurussi, Sreejith
collection PubMed
description We describe a new method for affinity purification of recombinant proteins using a dual protease protocol. Escherichia coli maltose binding protein (MBP) is employed as an N-terminal tag to increase the yield and solubility of its fusion partners. The MBP moiety is then removed by rhinovirus 3C protease, prior to purification, to yield an N-terminally His(6)-tagged protein. Proteins that are only temporarily rendered soluble by fusing them to MBP are readily identified at this stage because they will precipitate after the MBP tag is removed by 3C protease. The remaining soluble His(6)-tagged protein, if any, is subsequently purified by immobilized metal affinity chromatography (IMAC). Finally, the N-terminal His(6) tag is removed by His(6)-tagged tobacco etch virus (TEV) protease to yield the native recombinant protein, and the His(6)-tagged contaminants are removed by adsorption during a second round of IMAC, leaving only the untagged recombinant protein in the column effluent. The generic strategy described here saves time and effort by removing insoluble aggregates at an early stage in the process while also reducing the tendency of MBP to “stick” to its fusion partners during affinity purification.
format Online
Article
Text
id pubmed-4877217
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-48772172017-07-01 A dual protease approach for expression and affinity purification of recombinant proteins Raran-Kurussi, Sreejith Waugh, David S. Anal Biochem Article We describe a new method for affinity purification of recombinant proteins using a dual protease protocol. Escherichia coli maltose binding protein (MBP) is employed as an N-terminal tag to increase the yield and solubility of its fusion partners. The MBP moiety is then removed by rhinovirus 3C protease, prior to purification, to yield an N-terminally His(6)-tagged protein. Proteins that are only temporarily rendered soluble by fusing them to MBP are readily identified at this stage because they will precipitate after the MBP tag is removed by 3C protease. The remaining soluble His(6)-tagged protein, if any, is subsequently purified by immobilized metal affinity chromatography (IMAC). Finally, the N-terminal His(6) tag is removed by His(6)-tagged tobacco etch virus (TEV) protease to yield the native recombinant protein, and the His(6)-tagged contaminants are removed by adsorption during a second round of IMAC, leaving only the untagged recombinant protein in the column effluent. The generic strategy described here saves time and effort by removing insoluble aggregates at an early stage in the process while also reducing the tendency of MBP to “stick” to its fusion partners during affinity purification. Elsevier 2016-07-01 2016-04-19 /pmc/articles/PMC4877217/ /pubmed/27105777 http://dx.doi.org/10.1016/j.ab.2016.04.006 Text en Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Raran-Kurussi, Sreejith
Waugh, David S.
A dual protease approach for expression and affinity purification of recombinant proteins
title A dual protease approach for expression and affinity purification of recombinant proteins
title_full A dual protease approach for expression and affinity purification of recombinant proteins
title_fullStr A dual protease approach for expression and affinity purification of recombinant proteins
title_full_unstemmed A dual protease approach for expression and affinity purification of recombinant proteins
title_short A dual protease approach for expression and affinity purification of recombinant proteins
title_sort dual protease approach for expression and affinity purification of recombinant proteins
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877217/
https://www.ncbi.nlm.nih.gov/pubmed/27105777
http://dx.doi.org/10.1016/j.ab.2016.04.006
work_keys_str_mv AT rarankurussisreejith adualproteaseapproachforexpressionandaffinitypurificationofrecombinantproteins
AT waughdavids adualproteaseapproachforexpressionandaffinitypurificationofrecombinantproteins
AT rarankurussisreejith dualproteaseapproachforexpressionandaffinitypurificationofrecombinantproteins
AT waughdavids dualproteaseapproachforexpressionandaffinitypurificationofrecombinantproteins